Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06234631
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2024-01-22
Brief Title:
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty
Sponsor:
Chad Brummett
Organization:
University of Michigan
Study Overview
Official Title:
Cannabidiol for Postoperative Opioid Reduction in Primary Total Knee Arthroplasty - a Randomized Two by Two Factorial Double-blind Placebo-controlled Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CORK
Brief Summary:
The goal of this study is to better understand how daily treatment with cannabidiol CBD affects the need for opioid pain medication as well as pain inflammation and other related symptoms after knee replacement surgery The information collected in this study is necessary to help understand whether CBD may be a useful medication before andor after surgery
The study hypothesis is that CBD exerts opioid-sparing effects through anti-inflammatory analgesic and anxiolytic mechanisms
The study hypothesis is that CBD exerts opioid-sparing effects through anti-inflammatory analgesic and anxiolytic mechanisms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1U01AR083132-01 | NIH | None | httpsreporternihgovquickSearch1U01AR083132-01 |